Levothyroxine Crescent Pharma (Anhydrous Levothyroxine Sodium)

Levothyroxine is a synthetic form of thyroxine (T4). After oral absorption, it binds to nuclear thyroid hormone receptors, influencing gene transcription that regulates basal metabolic rate, protein synthesis, and growth. By increasing circulating T4, it reduces pituitary TSH secretion, thereby stabilizing thyroid function.

The appropriate dose of Levothyroxine Crescent Pharma is individualized by the prescribing clinician based on the patient’s age, weight, severity of hypothyroidism, cardiac status, and laboratory thyroid function tests. Patients should follow the exact dosing instructions provided by their healthcare professional.

Levothyroxine is classified as a pregnancy‑category drug only when clearly needed. Adequate maternal thyroid hormone is essential for fetal development, so the medication may be continued under medical supervision. Breastfeeding mothers should also discuss continuation with their physician, as levothyroxine is excreted in small amounts in milk.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Levothyroxine provides synthetic T4, the same hormone produced by a healthy thyroid gland, and is the standard of care for most hypothyroid patients. Alternatives such as liothyronine (T3) or combination T4/T3 products may be used in specific cases, but levothyroxine offers a predictable pharmacokinetic profile and is widely studied.

Store the tablets at ambient temperature, preferably below 25 °C, in the original blister pack or container. Protect them from moisture, excessive heat, and direct sunlight. Do not store in the bathroom or near a kitchen sink to maintain product stability.

Levothyroxine Crescent Pharma is taken orally, usually on an empty stomach, at least 30‑60 minutes before breakfast. Swallow the tablet whole with a full glass of water; do not crush or chew. Consistency in timing and food intake helps maintain stable blood levels.

Serious risks include cardiac arrhythmias, angina, myocardial infarction, severe bone loss (osteoporosis), allergic reactions such as rash or angioedema, and thyrotoxic crisis. Patients should promptly report chest pain, rapid heartbeat, severe bone pain, or signs of an allergic reaction to their healthcare provider.

Levothyroxine Crescent Pharma should be avoided in patients with untreated adrenal insufficiency, uncorrected thyrotoxicosis, or known hypersensitivity to levothyroxine or any excipients. Caution is also advised for individuals with recent myocardial infarction, uncontrolled cardiac disease, or severe osteoporosis, and use should be guided by a physician.